Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

2.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.9K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

414
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
414
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

251
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
251
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

397
The pathophysiology of pneumonia involves the following steps:
397
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

888
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
888

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical practice guidelines for the diagnosis and management of Charcot-Marie-Tooth disease.

Neurologia·2024
Same author

[Translated article] Aetiopathogenic factors and treatment of Müller-Weiss disease.

Revista espanola de cirugia ortopedica y traumatologia·2023
Same author

Etiopathogenic factors and treatment of Müller-Weiss disease.

Revista espanola de cirugia ortopedica y traumatologia·2023
Same author

[Chest impalement: Presentation of a case].

Semergen·2016
Same author

Interventional procedures in the chest.

Radiologia·2016
Same author

[Lung cancer screening].

Radiologia·2013

Related Experiment Video

Updated: Aug 11, 2025

Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

211

Idiopathic pulmonary fibrosis.

M Benegas Urteaga1, J Ramírez Ruz2, M Sánchez González1

  • 1Servicio de Radiodiagnóstico, CDI, Hospital Clínic de Barcelona, Barcelona, Spain.

Radiologia
|February 3, 2023
PubMed
Summary

Idiopathic pulmonary fibrosis (IPF) is a common lung disease with a poor prognosis. Early diagnosis through radiologist evaluation of high-resolution computed tomography (HRCT) findings is crucial for timely treatment and improved outcomes.

Keywords:
Computed tomographyEnfermedades pulmonares intersticialesFibrosis pulmonar idiopáticaIdiopathic pulmonary fibrosisInterstitial lung diseaseNeumonía intersticial usualTomografía computarizadaUsual interstitial pneumonia

More Related Videos

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

698
Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
06:29

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

Published on: May 5, 2023

2.6K

Related Experiment Videos

Last Updated: Aug 11, 2025

Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

211
Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

698
Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
06:29

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

Published on: May 5, 2023

2.6K

Area of Science:

  • Pulmonology and Radiology
  • Medical Imaging

Background:

  • Idiopathic pulmonary fibrosis (IPF) is the most prevalent fibrosing lung disease, characterized by a poor prognosis.
  • Early diagnosis of IPF is essential for initiating treatments that can delay disease progression.

Approach:

  • This review focuses on the role of radiologists in the evaluation and diagnosis of IPF.
  • It details the characteristic imaging patterns of IPF on high-resolution computed tomography (HRCT).
  • The review incorporates the latest international guidelines for IPF diagnosis and management.

Key Points:

  • Identifying specific HRCT patterns is crucial for accurate IPF diagnosis, often negating the need for surgical lung biopsies.
  • Radiologists are central to the multidisciplinary diagnostic process for IPF.
  • HRCT is vital for differential diagnosis, disease follow-up, and assessing complications.

Conclusions:

  • Accurate and early diagnosis of IPF, primarily through HRCT interpretation by radiologists, is fundamental for patient management.
  • This review provides a comprehensive overview of IPF, emphasizing imaging findings and their integration into clinical practice.